{"nct_id":"NCT03123588","title":"Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)","status":"TERMINATED","status_verified_date":"2021-10","start_date":"2017-11-14","start_date_type":"ACTUAL","primary_completion_date":"2020-08-03","primary_completion_date_type":"ACTUAL","completion_date":"2020-08-03","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["INCY"]}